Pharmaceutical Development and Commercialization
Generic Drug Manufacturing
Oncology Drug Portfolio
Complex Generics Production
505(b)2 Drug Development
New Chemical Entity (NCE) Development
Biosimilar Production
Regulatory Affairs and Compliance
Specialty Generics
Biosimilars
New Chemical Entities (NCEs)
Over-the-Counter (OTC) Products
Tail-End Brands
Oncology Drugs